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Background/introduction
Maximal homing of iv-infused MSC may be critical for
cell therapies. Molecular responses from the primarily
mechanical effects of pulsed focused ultrasound (pFUS)
(i.e., mechanotransduction) in healthy or diseased murine
kidneys generate a “molecular zip-code” consisting of
local increases in chemoattractants (cytokines, chemo-
kines, cell adhesion molecules) to enhance MSC homing.
These findings have substantial potential to improve cell
therapies for regenerative medicine. Since molecular sig-
naling post-pFUS drives enhanced MSC homing, other
drugs also aiming to treat disease could potentially inter-
fere with molecular responses and subsequent cell migra-
tion to targeted tissue thus undermining cell therapy
approaches. This study characterized temporal molecular
changes post-pFUS to identify critical signals that drive
larger changes observed in the chemoattractants and
investigates whether inhibition of the early signals could
suppress MSC homing to kidneys.
Methods
C3H mice received unilateral kidney pFUS (1MHz,
5MPa, 10 ms pulses, 5% duty cycle, VIFU 2000) and kid-
neys were harvested for ELISA from 10min–72hr after.
Pretreatment with drugs included: saline; ibuprofen (non-
specific cyclooxygenase [COX] inhibitor; 30mg/kg, po)
15min pre-pFUS; etanercept (tumor necrosis factor-a
inhibitor; 100μg, ip) 72 and 24hr pre-pFUS; or Anakinra
(interleukin-1a [IL-1a] inhibitor; 200μg, ip) 48, 24, and
1hr pre-pFUS. Drug-treated kidneys were harvested from
10min–24hr. MSC homing in normal or drug-treated
mice included 106 human MSC iv 3hr after kidney
pFUS.
Kidneys were harvested 24hr post-injection and MSC
were detected by immunofluorescence. Cell counts from
pFUS-treated kidneys were compared to untreated con-
tralateral kidneys and ANOVA was used for statistical
analysis (p<0.05).
Results and conclusions
Proteomic analyses of pFUS-treated kidneys revealed
early elevations of TNFa and IL-1a (10min), followed
by COX2 upregulation shortly thereafter (1–4hr). Thus
lead to chemoattractant elevations that induce MSC
homing (2–24hr) that returned to baseline by 72hr
(Fig 1). Kidneys in mice pretreated with ibuprofen, eta-
nercept, or anakinra, did not generate the molecular
zip-code after pFUS. Infused MSC did not home to
pFUS-treated kidneys. MSC also failed to home to
pFUS-treated kidneys in COX2-knockout mice, demon-
strating ibuprofen inhibited COX2 specifically. Drug
effects on cell homing remain unexplored and uncon-
trolled for in cell therapy trials. The molecular zip-code
generated by pFUS is driven by early elevations of
TNFa and IL1a and COX2 expression. Inhibiting any of
these molecules with clinically relevant drugs abrogates
the pFUS-induced molecular response and suppresses
MSC homing to kidneys. These findings suggest drug-
host interactions could undermine cell-based therapies
in regenerative medicine. Furthermore, in-depth study
of pFUS molecular responses may help elucidate MSC
homing mechanisms and pFUS could be a useful plat-
form to screen drug-homing interactions.
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Figure 1 Bloxplot representation of statistically significant (p<0.05 by ANOVA) elevations in cytokines, chemokines, growth factors, and cell
adhesion molecules following pFUS to normal kidneys. Responses enhance MSC homing and are inhibited by clinical drugs.
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